Smith & Nephew plc vs Verisign, Inc. — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Verisign, Inc. trades at $277.5 (market cap $25.26B). The key difference: Verisign, Inc. is the larger of the two by market cap, and Smith & Nephew plc pays the higher dividend (2.57%). Which is the better fit depends on your goals.
| SNN | VRSN | |
|---|---|---|
Market Cap | $12.64B | $25.26B |
Sector | Health | Technology |
52-Week High | $38.70 | $310.00 |
52-Week Low | $28.73 | $211.49 |
Enterprise Value | $15.41B | $26.50B |
Dividend Yield | 2.57% | 1.17% |
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →